Table I.
Sample characteristics.
Patient/tumor traits | Subgroups/no. of samples |
---|---|
Age at primary diagnosis, years | |
<50 | 11 |
50–60 | 55 |
60–70 | 69 |
70–80 | 50 |
>80 | 18 |
Tumor size | |
T1 | 166 |
T2 | 15 |
T3 | 17 |
T4 | 5 |
Lymph node status | |
Nx | 57 |
N0 | 135 |
N1 | 11 |
Metastasis status | |
Mx | 76 |
M0 | 124 |
M1 | 3 |
Grading | |
G1 | 113 |
G2 | 68 |
G3 | 22 |
ERα | |
Positive | 92 |
Negative | 111 |
ERβ | |
Positive | 28 |
Negative | 175 |
PRA | |
Positive | 92 |
Negative | 111 |
PRB | |
Positive | 103 |
Negative | 100 |
ER, estrogen receptor; PR, progesterone receptor.